A cost-benefit analysis of an advocacy project to fluoridate toothpastes in Nepal Yee R, McDonald N, Walker D

Similar documents
Is hospitalization after TIA cost-effective on the basis of treatment with tpa? Nguyen Huynh M N, Johnston S C

Setting The setting was the community. The economic study was carried out in the USA.

Setting The setting was the community. The economic study was conducted in Yokohama city, Japan.

Quitline in smoking cessation: a cost-effectiveness analysis Tomson T, Helgason A R, Gilljam H

The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T

Setting The setting of the study was primary care. The economic study was conducted in Canada.

Source of effectiveness data The effectiveness data were derived from a review of completed studies and authors' assumptions.

Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China Ding D, Kilgore P E, Clemens J D, Liu W, Xu Z Y

Economic evaluation of tandem mass spectrometry screening in California Feuchtbaum L, Cunningham G

The cost-effectiveness of anorexia nervosa treatment Crow S J, Nyman J A

A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis Das A

Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis.

Cost-effectiveness of pediatric heart transplantation Dayton J D, Kanter K R, Vincent R N, Mahle W T

Economic implications of early treatment of migraine with sumatriptan tablets Cady R K, Sheftell F, Lipton R B, Kwong W J, O'Quinn S

Cost-effectiveness of a community-level HIV risk reduction intervention Pinkerton S D, Holtgrave D R, DiFranceisco W J, Stevenson L Y, Kelly J A

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M

Economic analysis of initial HIV treatment: efavirenz- versus indinavir-containing triple therapy Caro J J, O'Brien J A, Miglaccio-Walle K, Raggio G

Cost-effectiveness of colonoscopy in screening for colorectal cancer Sonnenberg A, Delco F, Inadomi J M

Determining the cost-effectiveness of mass screening for cervical cancer using common analytic models Sato S, Matunaga G, Tsuji I, Yajima A, Sasaki H

Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R

Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids Beinfeld M T, Bosch J L, Isaacson K B, Gazelle G S

Cost-effectiveness of intraoperative facial nerve monitoring in middle ear or mastoid surgery Wilson L, Lin E, Lalwani A

Pertussis in adolescents and adults: should we vaccinate Lee G M, LeBaron C, Murphy T V, Lett S, Schauer S, Lieu T A

Cost-effectiveness of preventing hip fracture in the general female population Kanis J A, Dawson A, Oden A, Johnell O, de Laet C, Jonsson B

Cost-effectiveness of HIV post-exposure prophylaxis in France Herida M, Larsen C, Lot F, Laporte A, Desenclos J C, Hamers F F

Cost-effectiveness of gastric bypass for severe obesity Craig B M, Tseng D S

An economic assessment of pre-vaccination screening for hepatitis A and B Jacobs R J, Saab S, Meyerhoff A S, Koff R S

Health technology Lower-extremity amputation prevention strategies among individuals with diabetes.

The cost-effectiveness of screening blood donors for malaria by PCR Shehata N, Kohli M, Detsky A

Setting The setting was a hospital and the community. The economic analysis was carried out in the USA.

The DiSC assay: a cost-effective guide to treatment for chronic lymphocytic leukemia? Mason J M, Drummond M F, Bosanquet A G, Sheldon T A

Cost-effectiveness of in vitro fertilisation and embryo transfer Mol B W, Bonsel G J, Collins J A, Wiegerinck M A, van der Veen F, Bossuyt P M

Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam Tavakoli M

Pharmaco-economic aspects of in-vitro fertilization in Italy Mantovani L G, Belisari A, Szucs T D

Type of intervention Screening and treatment. Economic study type Cost-utility analysis.

Cost-effectiveness considerations in the treatment of essential thrombocythemia Golub R, Adams J, Dave S, Bennett C L

Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis Kantor J, Margolis D J

Comparison of safety and cost of percutaneous versus surgical tracheostomy Bowen C P R, Whitney L R, Truwit J D, Durbin C G, Moore M M

Cost effectiveness of human immunodeficiency virus postexposure prophylaxis for healthcare workers Scheid D C, Hamm R M, Stevens K W

Study population Patients in the UK, with moderate and severe depression, and within the age range 18 to 93 years.

Cost-effectiveness analysis of screening for celiac disease in the adult population Shamir R, Hernell O, Leshno M

Study population The study population comprised newly diagnosed, symptomatic myeloma patients under the age of 60.

Clinical impact and health economic consequences of post-transplant type 2 diabetes mellitus Chilcott J B, Whitby S M, Moore R

Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis Bayoumi A M, Redelmeier D A

The utility of bladder catheterization in total hip arthroplasty Iorio R, Whang W, Healy W L, Patch D A, Najibi S, Appleby D

The case for daily dialysis: its impact on costs and quality of life Mohr P E, Neumann P J, Franco S J, Marainen J, Lockridge R, Ting G

Setting The study setting was secondary care. The economic study was carried out in Norway.

Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions Fearon W F, Yeung A C, Lee D P, Yock P G, Heidenreich P A

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation Nielsen K, Fiore M C

Setting The setting was tertiary care. The economic study was conducted in Bangkok, Thailand.

Health technology Three screening strategies for developmental dysplasia of the hip (DDH) were examined:

Source of effectiveness data The effectiveness evidence came from a review of published studies and the authors' assumptions.

Source of effectiveness data The evidence for final outcomes was derived from a review of the literature and a single survey study.

Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanoma Hillner B E

Setting The setting was secondary care. The economic study was conducted in Australia.

The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S

Screening for malignant melanoma: a cost-effectiveness analysis Freedberg K A, Geller A C, Miller D R, Lew R A, Koh H K

Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis Wingard J R, Wood C A, Sullivan E, Berger M L, Gerth W C, Mansley E C

Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis Little S E, Caughey A B

Setting The setting was secondary care. The economic study was carried out in Denver (CO), USA.

Health technology Immediate in vitro fertilisation (IVF) was compared with gonadotropins followed by IVF as treatment for primary infertility.

The cost-effectiveness of raising the legal smoking age in California Ahmad S

Prenatal purified protein derivative skin testing in a teaching clinic with a large Hispanic population Medchill M T

Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment Pohl H, Finlayson S R, Sonnenberg A, Robertson D J

The economic impact of quarantine: SARS in Toronto as a case study Gupta A G, Moyer C A, Stern D T

Health technology Endoscopic surveillance of Barrett's oesophagus to detect malignancy in an early and curable stage.

Economic effects of beta-blocker therapy in patients with heart failure Cowper P A, DeLong E R, Whellan D J, LaPointe N M, Califf R M

Setting The setting was primary care. The economic study was carried out in the USA.

Health technology Sumatriptan therapy was compared with nontriptan medications in the treatment of acute migraine.

Is medical treatment for angina the most cost-effective option? Cleland J G, Walker A

Study population The study population comprised a hypothetical cohort of patients with confirmed reflux oesophagitis.

Cost-effectiveness of influenza vaccination in high-risk children in Argentina Dayan G H, Nguyen V H, Debbag R, Gomez R, Wood S C

Setting The setting was community. The economic study was carried out in the USA.

An economic evaluation of lung transplantation Anyanwu A C, McGuire A, Rogers C A, Murday A J

Cefazolin versus cefazolin plus metronidazole for antibiotic prophylaxis at Cesarean section Meyer N L, Hosier K V, Scott K, Lipscomb G H

Health technology Three strategies for influenza A outbreaks in long-term care facilities (LTCFs) with high staff vaccination were compared:

The incidence of shingles and its implications for vaccination policy Chapman R S, Cross K W, Fleming D M

Outcomes assessed in the review The review assessed adverse events, probability of discontinuation, toxicity, impotence, and survival.

An economic evaluation of a school-based sexually transmitted disease screening program Wang L Y, Burstein G R, Cohen D A

Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine Zhang L, Hay J W

Setting The setting was outpatient. The economic study was carried out in the USA.

Source of effectiveness data The effectiveness data were derived from a review or synthesis of completed studies.

Comparison of haemodialysis and peritoneal dialysis: a cost-utility analysis Sennfalt K, Magnusson M, Carlsson P

Setting The setting was secondary care. The economic study was carried out in Hawaii, USA.

The cost-effectiveness of syndromic management in pharmacies in Lima, Peru Adams E J, Garcia P J, Garnett G P, Edmunds W J, Holmes K K

The cost-utility of screening for depression in primary care Valenstein M, Vijan S, Zeber J E, Boehm K, Buttar A

Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1 Halpern M T, Read J S, Ganoczy D A, Harris D R

Setting The study setting was the community. The economic analysis was conducted in the USA.

Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Comparative cost-effectiveness of four-layer bandaging in the treatment of venous leg ulceration Carr L, Philips Z, Posnett J

Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura Kumar M, Vik T A, Johnson C S, Southwood M E, Croop J M

the use of a combination of diphtheria, tetanus, and whole-cell pertussis vaccine (DTwP); and

A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia Sculpher M

Cost-effectiveness of a pediatric dengue vaccine Shepard D S, Suaya J A, Halstead S B, Nathan M B, Gubler D J, Mahoney R T, Wang D N, Meltzer M I

Gastric ulcers at endoscopy: brush, biopsy, or both Sadowski D C, Rabeneck L

A randomized crossover study of silver-coated urinary catheters in hospitalized patients Karchmer T B, Giannetta E T, Muto C A, Strain B A, Farr B M

Setting The setting was hospital. The economic analysis was conducted in Toronto, Montreal and Laval, Canada.

Transcription:

A cost-benefit analysis of an advocacy project to fluoridate toothpastes in Nepal Yee R, McDonald N, Walker D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined an advocacy project for promoting the use of fluoridated toothpaste. Type of intervention Primary prevention. Economic study type Cost-benefit analysis. Study population The study population comprised children aged between 6 and 18 years. Setting The setting was the community. The economic study was carried out in Nepal. Dates to which data relate The effectiveness data related to 2002 to 2007. The resource use data related to 1997 to 2007. The price year was 2002. Source of effectiveness data The effectiveness data were derived from a review of published studies and authors' assumptions. Modelling A mathematical model was used to calculate the net present value of the advocacy project. The method used for the model was described in another paper (Yee et al. 2002, see 'Other Publications of Related Interest' below for bibliographic details). The timeframe for the present value benefit analysis was 6 years, from the base year 2002 to 2007. The timeframe for the present value cost analysis was 6 years, from the start of the advocacy project in 1997 to the base year 2002. Outcomes assessed in the review The outcomes assessed in the review included: the prevalence of caries, the number of tooth surfaces requiring treatment, the prospective mean number of decayed, missing or filled teeth (DMFT) for the age cohort, and Page: 1 / 5

the amalgam failure rate. Study designs and other criteria for inclusion in the review Sources searched to identify primary studies Criteria used to ensure the validity of primary studies Methods used to judge relevance and validity, and for extracting data Number of primary studies included The number of primary studies included in the review was unclear. Methods of combining primary studies No formal synthesis was undertaken. Any combining of the primary studies was based on authors' assumptions. Investigation of differences between primary studies Potential differences between the primary studies were not discussed in the analysis. Results of the review The review resulted in an estimate of 0.9 for current 12-year-old DMFT. The use of fluoride toothpaste was estimated to have increased from 1 to 75% following the advocacy project. Brushing once a day with fluoride toothpaste was estimated to reduce caries by between 12 and 40%. The amalgam failure rate was 7%. The average caries prevalence of the mixed age group was 44%. This was derived from the mathematical model. Methods used to derive estimates of effectiveness Authors' assumptions were used to derive parameters for the mathematical model (Yee et al. 2002). Estimates of effectiveness and key assumptions The authors assumed the population of 6- to 18-year-olds would grow by 2% per annum. In addition, 12-year-old DMFT would increase from 0.9 in 2002 to 1.5 by year 2007 without the benefit of fluoride toothpaste. Measure of benefits used in the economic analysis Monetary health benefits were calculated for the economic analysis. The health benefits were assumed to be the reduction in financial burden of treating caries. This can be considered a cost-saving rather than a health benefit. The Page: 2 / 5

authors acknowledged that the study was limited by its failure to place a monetary value on health outcomes such as reduced toothache. Direct costs Discounting was relevant as the period of analysis was greater than 1 year. A rate of 5% per annum was used. The costs included were for the advocacy project and dental treatment. The cost of the advocacy project included personnel for water analysis, equipment and chemicals for fluoride analysis, training costs, printing, postage and stationary, rent and utilities, transportation costs and travel expenses, and preparation of presentations. The authors acknowledged that the failure to include transport costs and other patient costs beyond the cost of the dental treatment procedures themselves was a limitation of the study. The resource quantities and the unit costs were derived from the literature. The unit costs were estimated on the basis of average charges. The price year was 2002, and no adjustments for inflation were made. Statistical analysis of costs Sample data were not available, thus a statistical analysis of the costs was not possible. Indirect Costs The indirect costs were not included in the analysis. Currency US dollars ($). The conversion rates were not reported. Sensitivity analysis One-way and multi-way sensitivity analyses were undertaken to explore variability in the data, as measured by ranges reported in the literature, and to test the authors' assumptions. Estimated benefits used in the economic analysis The monetary economic benefits consisted of cost-savings from preventing restorative treatment. Over 6 years and using a discount rate of 5%, these were estimated to be $601,315 for a 10% reduction in caries, $1,042,489 for a 20% reduction in caries, and $2,449,182 for a 40% reduction in caries. Cost results The total intervention cost was $6,849 when using a discount rate of 5%. No statistical analysis was undertaken. Synthesis of costs and benefits The costs and benefits were synthesised to calculate the net present value of the advocacy project. The net present value was $594,466 for a 10% reduction in caries, $1,035,640 for a 20% reduction in caries, and $2,442,333 for a 40% reduction in caries. Benefit-to-cost ratios were estimated to be 87 for a 10% reduction in caries, 151 for a 20% reduction in caries, and 356 for a 40% reduction in caries. The results were reported in 2002 US$ using a discount rate of 5%. Authors' conclusions The advocacy project was efficient and produced tangible benefits in the form of reduced financial burden for treating Page: 3 / 5

caries. CRD COMMENTARY - Selection of comparators The choice of the comparator was current practice in Nepal. You must assess whether current levels of fluoride use and caries in Nepal are representative of your own setting. Validity of estimate of measure of effectiveness The measure of effectiveness was based on the reduction in caries. The authors did not state that a systematic review of the literature was undertaken, and they did not clearly report the methods used for their review. They may, therefore, have used the available evidence selectively, thus introducing bias into the study results. The authors justified their assumptions with reference to the published literature, and explored the variation in reported effectiveness using a sensitivity analysis. They acknowledged that their study relied on estimates, and stated that future studies would be able to confirm whether their assumptions were justified. Validity of estimate of measure of benefit The estimation of health benefit was modelled to provide the reduced financial burden of dental treatment. The authors acknowledged that they failed to place a monetary value on health benefits resulting from a reduction in caries, such as reduced toothache. Validity of estimate of costs Although the study was conducted from a societal perspective, the authors acknowledged that they failed to include the indirect costs in the form of productivity losses. They also acknowledged that they did not include transport costs and other costs to the patients, beyond the cost of dental procedures. The omission of indirect and other costs should not have affected the authors' conclusions, as their inclusion would likely favour the intervention. The resource use quantities were not reported separately from the costs, which may reduce the generalisability of the study results. Sensitivity analyses were conducted around the reduced number of dental procedures, but not the unit cost of those procedures. The authors did not report their currency conversions. The price year was reported, which will enhance any future inflation exercises. Discounting was adequately applied as the study horizon was longer than 2 years. Other issues The authors made appropriate comparisons of their results with findings from other analyses of public and community health initiatives to reduce caries. They did not attempt to generalise the findings of their study beyond Nepal. The results were not presented selectively. The authors stated several limitations of their study, which have been highlighted already. Implications of the study The authors did not make any explicit recommendations for changes in policy or practice. With the exception of future studies to confirm the model assumptions, no further research was explicitly identified. Source of funding Supported by TearFund UK and InterAct Sweden. Bibliographic details Yee R, McDonald N, Walker D. A cost-benefit analysis of an advocacy project to fluoridate toothpastes in Nepal. Community Dental Health 2004; 21(4): 265-270 PubMedID Page: 4 / 5

Powered by TCPDF (www.tcpdf.org) 15617410 Other publications of related interest Yee R, Sheiham A. The burden of restorative dental treatment for children of Third World countries. International Dental Journal 2002;52:1-9. Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Cariostatic Agents /administration & dosage /economics; Child; Cost-Benefit Analysis /methods; Dental Caries /prevention & control; Fluorides /administration & dosage /economics; Health Promotion /methods; Humans; Nepal; Primary Prevention /methods; Toothpastes /chemistry /economics AccessionNumber 22005006110 Date bibliographic record published 31/01/2006 Date abstract record published 31/01/2006 Page: 5 / 5